According to the recent research report titled ‘GLOBAL Biopsy Device Market 2019-2027’, available with Market Study Report, global biopsy device market is anticipated to record a CAGR of 6.82% during 2019-2027.
 

As per the findings of the report, rising cognizance among the elderly population regarding disease diagnostics solutions and increasing pervasiveness of cancer are propelling global biopsy device market growth. Surging demand for invasive procedures is also adding significant traction to the industry development.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2487033/
 

For those unversed, the removal of tissue from any part of the body for the purpose of examining the existence of any disease (usually cancer) is referred to as a biopsy. Biopsy can be performed on any organ of the body with the aid of a specific biopsy kit. Biopsy procedures are often conducted using a variety of devices in essential body parts such as the kidney, liver, lungs, and prostate.
 

Growing prevalence of liver diseases is leading to an increase in the number of liver biopsy tests that employ a variety of instruments to remove samples from areas of concern. Furthermore, advancements in biopsy techniques are expected to accelerate global biopsy device industry progression.
 

Despite the favorable business scenario, lack of technical expertise, high cost of biopsy devices manufactured using sophisticated techniques, and limitations of biopsies are slowing the industry expansion.
 

Based on device type, global biopsy device market is split into robotic guidance system, gynecological biopsy device, bronchial biopsy, soft tissue biopsy needles, gastrointestinal (GI) biopsy, breast biopsy, and others. With respect to therapeutic area, the market is divided into gynecological biopsy, kidney biopsy, lung biopsy, liver biopsy, prostate biopsy, GI biopsy, breast biopsy, and others.
 

As per display technologies, the industry is classified into CT-guided biopsy, ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and others. Moving on, the end user segmentation comprises diagnosis center and hospitals.
 

On the regional front, North America holds major portion of global biopsy device market share owing to a presence of a well-developed healthcare system that allows for easy access and technologically advanced diagnostic solutions such as biopsies. Moreover, rising cases of cancer is stimulating the regional industry growth.
 

Top players swaying global biopsy device market dynamics are Ad-Tech Medical Instrument Corp., Cook Group Inc., B. Braun Melsungen AG, Cardinal Health Inc., Argon Medical Devices Inc., Fischer Medical Technologies LLC, Cintec Medical Ltd., Boston Scientific Corp., C. R. Bard Inc., Planmeca Oy, I.M.S. Internazionale Medico Scientifica SRL, Qiagen N.V., and Becton, Dickinson and Company.